French Quantum Startup Pasqal Eyes $2 Billion Nasdaq IPO
▼ Summary
– Pasqal, a French neutral-atom quantum computing company co-founded by Nobel laureate Alain Aspect, has agreed to a business combination with a SPAC, targeting a Nasdaq listing in late 2026 with a pre-money valuation of $2 billion.
– The deal structure includes approximately $200 million in committed financing and could yield over $600 million in total proceeds, alongside a separate $395 million funding round announced in anticipation of the listing.
– Pasqal builds quantum computers by trapping and manipulating individual atoms with lasers, an architecture it claims offers advantages in connectivity and scalability over competing superconducting systems.
– The potential listing represents a significant milestone for European deep tech, as EU quantum investment has lagged behind the US and China, and a successful public debut could boost commercial confidence in the region.
– The quantum computing sector continues to attract investment despite the technology’s early stage, with the key commercial question being the timeline to practical utility rather than the validity of the underlying science.
A French pioneer in quantum computing is poised for a significant leap onto the global financial stage. Pasqal, the neutral-atom quantum company co-founded by Nobel laureate Alain Aspect, has entered into a definitive agreement to merge with a special purpose acquisition company (SPAC). This strategic move aims to secure a Nasdaq listing in the latter half of 2026, with the combined entity targeting a substantial pre-money valuation of two billion dollars. The announcement signals a major step for European deep tech, highlighting the growing commercial ambition within the quantum sector.
The proposed business combination with Bleichroeder Acquisition Corp. II is structured to deliver considerable capital. Initial reports indicate the deal includes around two hundred million dollars in committed convertible financing, with the potential for total proceeds to exceed six hundred million. In a parallel development underscoring investor confidence, Pasqal separately closed a sizable funding round of three hundred ninety-five million dollars. This round attracted capital from notable entities including Parkway, Quanta Computer, LG Electronics, and the global shipping group CMA CGM, which has shown increasing interest in next-generation computing infrastructure.
Pasqal’s technological foundation distinguishes it from many competitors. While industry giants like IBM and Google focus on superconducting qubit systems, Pasqal builds quantum processors using arrays of neutral atoms. Their method involves trapping individual atoms with precisely controlled lasers and manipulating their quantum states. The company advocates for this architecture, claiming it offers superior pathways for connecting qubits and scaling up system size, two critical challenges in the field. Currently, the company manages seven quantum systems and collaborates with over twenty-five commercial clients and partners, though specific revenue details remain private.
The path to a public listing is becoming a more familiar one for quantum startups. Pasqal joins a queue of companies seeking access to public capital markets, following the trail blazed by IonQ’s SPAC merger in 2021. This sustained investor interest persists despite a widely acknowledged reality: today’s quantum computers are primarily tools for research and specialized optimization, not yet the fault-tolerant, general-purpose machines envisioned for the future. The commercial timeline, rather than the underlying science, represents the central uncertainty for the market.
For Europe’s technology ecosystem, a successful Nasdaq debut by Pasqal would carry symbolic and practical weight. Investment in quantum computing across the European Union has historically trailed commitments made in the United States and China. A high-profile listing of a French company, backed by a Nobel-winning scientist, could enhance the region’s visibility and bolster confidence in its ability to translate world-class research into competitive commercial ventures. However, the transaction is not finalized, requiring regulatory and shareholder approvals. Potential investors will likely consider the mixed post-listing performance of other quantum SPACs, recognizing that the announced valuation represents an ambitious starting point for a journey that is just beginning.
(Source: The Next Web)
